New York, Nov 25 (IANS) Exposure to fine particulate air pollutants from coal-fired power plants (coal PM2.5) is associated with a risk of mortality more than double that of exposure to PM2.5 from other sources, say researchers after examining emissions data and Medicare records.
San Francisco, Nov 25 (IANS) Decreasing the widely used Covid-19 booster vaccine dose produces a similar immune response in adults as compared to a full dose with fewer side effects, a new study has found.
San Francisco, Nov 25 (IANS) Swapping animal-based food such as red and processed meat with plant-based foods such as nuts or legumes may help lower the risk of cardiovascular disease (CVD), type 2 diabetes, coronary heart disease, and overall mortality, a new study has found.
London, Nov 25 (IANS) A new study led by University College London (UCL) researchers confirms that autistic people experience a reduced life expectancy, however the number of years of life lost may not be as high as previously claimed.
London, Nov 25 (IANS) Researchers are now developing and using methods based on artificial intelligence (AI) to recognise the tempo and stages of embryonic development.
London, Nov 24 (IANS) Under new curbs on immigration planned by the UK government, foreign health and care workers will be allowed to bring only one relative with them to the country, media reports said.
Sydney, Nov 24 (IANS) Researchers have identified four drugs that can reverse a cellular process triggered by Covid-19 that contributes to premature ageing of the brain.
New York, Nov 24 (IANS) A novel artificial intelligence (AI) tool can identify non-smokers who are at high risk for lung cancer using a routine chest X-ray image, according to researchers, including one of Indian-origin.
New Delhi, Nov 24 (IANS) The Alzheimer's disease market is projected to reach $16 billion in 2030, according to a report on Friday.
Copenhagen, Nov 24 (IANS) The World Health Organization (WHO) has warned against the misuse of antibiotics which could result in up to 10 million deaths a year by 2050 due to antimicrobial resistance (AMR).
